Role of TGF-beta signaling in extracellular matrix production under high glucose conditions.
暂无分享,去创建一个
Hong-Jian Zhu | H. Lan | Xiao-ru Huang | Jin H Li | Richard Johnson | Richard J. Johnson | Xiao R. Huang
[1] S. Hong,et al. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells. , 2002, Biochemical and biophysical research communications.
[2] Hong-Jian Zhu,et al. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. , 2002, Journal of the American Society of Nephrology : JASN.
[3] Ruihua Chen,et al. Blockade of the effects of TGF-beta1 on mesangial cells by overexpression of Smad7. , 2002, Journal of the American Society of Nephrology : JASN.
[4] D. Warburton,et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[5] F. Marumo,et al. Gene transfer of Smad7 using electroporation of adenovirus prevents renal fibrosis in post-obstructed kidney. , 2002, Kidney international.
[6] E. Bottinger,et al. Apoptosis in podocytes induced by TGF-β and Smad7 , 2001 .
[7] M. Isono,et al. Increased Glomerular and Tubular Expression of Transforming Growth Factor-β1, Its Type II Receptor, and Activation of the Smad Signaling Pathway in the db/db Mouse , 2001 .
[8] M. D. de Caestecker,et al. Transcriptional Cross-talk between Smad, ERK1/2, and p38 Mitogen-activated Protein Kinase Pathways Regulates Transforming Growth Factor-β-induced Aggrecan Gene Expression in Chondrogenic ATDC5 Cells* , 2001, The Journal of Biological Chemistry.
[9] E. Frohlich,et al. Diabetes, Hypertension, and Cardiovascular Disease: An Update , 2001, Hypertension.
[10] H. Schnaper,et al. Sp1 and Smad Proteins Cooperate to Mediate Transforming Growth Factor-β1-induced α2(I) Collagen Expression in Human Glomerular Mesangial Cells* , 2001, The Journal of Biological Chemistry.
[11] N. Hotta,et al. Role of PKC and TGF-beta receptor in glucose-induced proliferation of smooth muscle cells. , 2001, Biochemical and biophysical research communications.
[12] S. Hong,et al. THE KEY ROLE OF THE TRANSFORMING GROWTH FACTOR-β SYSTEM IN THE PATHOGENESIS OF DIABETIC NEPHROPATHY , 2001 .
[13] H. Nick,et al. Smad7-dependent Regulation of Heme Oxygenase-1 by Transforming Growth Factor-β in Human Renal Epithelial Cells* , 2000, The Journal of Biological Chemistry.
[14] J. Wrana,et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.
[15] W. B. Reeves,et al. Transforming growth factor β contributes to progressive diabetic nephropathy , 2000 .
[16] K. Sharma,et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. W. Padgett,et al. Transforming growth factor β signaling mediators and modulators , 2000 .
[18] D. C. Han,et al. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. , 2000, American journal of physiology. Renal physiology.
[19] J. Massagué,et al. Controlling TGF-β signaling , 2000, Genes & Development.
[20] F. Locatelli,et al. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] H. Schnaper,et al. The transforming growth factor-βbgr/SMAD signaling pathway is present and functional in human mesangial cells , 1999 .
[22] D. C. Han,et al. High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. , 1999, Journal of the American Society of Nephrology : JASN.
[23] K. Miyazono,et al. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. , 1999, The Journal of clinical investigation.
[24] K. Sharma,et al. Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. , 1998, Kidney international.
[25] M. Cooper,et al. Pathogenesis, prevention, and treatment of diabetic nephropathy , 1998, The Lancet.
[26] J. Massagué,et al. SMADs: mediators and regulators of TGF-β signaling , 1998 .
[27] C. Heldin,et al. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.
[28] Tatsuo Yamamoto,et al. Transforming Growth Factor in Diabetic Nephropathy , 1996 .
[29] T. Yamamoto,et al. Transforming Growth Factor β in Diabetic Nephropathy , 1996 .
[30] Jia Guo,et al. Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic Mice , 1996, Diabetes.
[31] K. Sharma,et al. Hyperglycemia and Diabetic Kidney Disease: The Case for Transforming Growth Factor–β as a Key Mediator , 1995, Diabetes.
[32] A. Schmidt,et al. The dark side of glucose , 1995, Nature Medicine.
[33] K. Sharma,et al. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. , 1994, The Journal of clinical investigation.
[34] M. Rocco,et al. Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. , 1992, Kidney international.
[35] S. Nelson,et al. Relationship of Microvascular Disease in Diabetes to Metabolic Control , 1977, Diabetes.